It seems that biotechnology is finding investors in our country. A few weeks ago we told you that Inveready had invested in Cuantum and Ab-biotics, this week we learned that Oncostellae, which received a €1M round is looking for funding, and Caixa Capital Risk has led a €2.2M round in Inbiomotion.
M&A advisors with expertise in the technology sector
caixa
Latest Sectoral Reports |
Last Entries